MedPath
NMPA Approval

Montelukast Sodium Oral Granules

国药准字H20203429

August 17, 2020

Drug Information

孟鲁司特钠颗粒

宁淞

颗粒剂

0.5g:4mg(以孟鲁司特计)

化学药品

August 17, 2020

Company Information

Applicant Company

苏州工业园区江浦路8号

Manufacturing Company

苏州工业园区星湖街218号生物纳米科技园C30楼

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

孟鲁司特钠颗粒 - NMPA 批准文号 | MedPath